Boston Scientific's endoscope business grows by over 20 percent

Although endoscope sales at US-based Boston Scientific have had a good year in 2021, the company has seen its bottom line halved during its latest financial year.
Like Danish company Ambu, US-based Boston Scientific sells devices for endoscopy | Photo: Ambu / PR
Like Danish company Ambu, US-based Boston Scientific sells devices for endoscopy | Photo: Ambu / PR
by ULRICH QUISTGAARD, translated by daniel pedersen

In 2021, Boston Scientific added 20.3 percent to its endoscopy business, and sold endoscopes for USD 2.14bn, compared to 2020’s result of USD 1.78bn, the company reports in its full-year 2021 financial report.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading